Waystar AI Delivers Industry-Leading Outcomes, Earns #1 Client Ranking
MWN-AI** Summary
Waystar, a healthcare payment software provider, has been recognized for its exceptional AI capabilities, earning the top ranking in client satisfaction according to a recent independent survey conducted by Black Book Market Research. This study involved over 750 senior healthcare leaders and evaluated 49 revenue cycle management (RCM) vendors. Waystar achieved an impressive composite score of 9.75 out of 10 across 18 key performance indicators, significantly exceeding its next closest competitor's score of 8.27. Nearly all surveyed clients indicated a strong likelihood of renewing their engagements with Waystar, highlighting the platform's ability to deliver meaningful value.
The survey underscored Waystar's leadership in AI execution, noting the company’s superior performance in areas such as time-to-value and ROI clarity. Waystar AltitudeAI™, an integral part of the platform, has delivered significant operational results, including the prevention of $15 billion in denials and a 90% acceleration in appeal package generation. The platform boasts clean claim and first-pass acceptance rates of around 99%, driving quicker reimbursements for healthcare providers.
Matt Hawkins, CEO of Waystar, attributes this success to the company's mission-critical infrastructure, extensive proprietary data, and deep domain expertise. Clients like Piedmont Healthcare have benefitted from Waystar's AI-driven automation, which streamlines authorizations and enhances accuracy, thereby optimizing operational effectiveness.
Overall, Waystar's innovations in AI and commitment to improving revenue cycle management positions it as a frontrunner in the healthcare payment sector, allowing providers to focus more on patient care and less on administrative challenges.
MWN-AI** Analysis
Waystar's recent recognition as the number one provider in client satisfaction within the revenue cycle management (RCM) industry reflects its robust AI capabilities and strong market position. With a composite score of 9.75 out of 10 across key performance indicators, Waystar significantly outperformed competitors, evidencing not only its dominance but also the increasing reliance on artificial intelligence in healthcare payment systems.
Investors should view Waystar as a compelling opportunity given its demonstrated ability to deliver superior value through its AI platform, Waystar AltitudeAI™, which has already shown marked success by preventing $15 billion in denials and drastically reducing processing time for appeals. These innovations not only enhance operational efficiency but also promise to yield higher returns on investment for healthcare organizations, reflecting broader market trends favoring automation and data-driven decision-making in the healthcare industry.
Furthermore, the overwhelming loyalty from clients, with nearly 100% indicating they would renew their AI engagements, suggests a stable revenue forecast for Waystar. This statistic, combined with its extensive client base—which includes major healthcare institutions—indicates strong market resilience and operational effectiveness.
From a stock market perspective, Waystar (Nasdaq: WAY) could see continued upside potential. The advanced technology infrastructure and proprietary data give it a competitive edge, positioning it well for future growth in an evolving healthcare landscape. Additionally, as the demand for streamlined healthcare services increases, Waystar is poised to capture additional market share.
In conclusion, Waystar's industry-leading outcomes and commitment to innovation place it in a favorable position for investors. As healthcare continues to transition towards more automated and efficient models, Waystar’s stock presents a viable investment opportunity worth considering.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
Black Book survey of more than 750 healthcare leaders demonstrates that Waystar leads the industry in client satisfaction with AI execution and outcomes
LEHI, Utah, and LOUISVILLE, Ky., Feb. 20, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that its AI capabilities earned the top ranking in the revenue cycle management industry, according to an independent survey by Black Book Market Research™ focused on agentic and generative AI in revenue cycle management.
Waystar earned the top overall ranking across client-reported outcomes, execution, and satisfaction — outperforming all peers on core measures of AI value realization. The survey evaluated 49 RCM vendors and captured insights from more than 750 senior healthcare leaders across provider sizes and care settings.
Key survey findings include:
- Highest satisfaction and exceptional loyalty: Waystar earned a 9.75 out of 10 composite score across 18 key performance indicators — outpacing the next highest competitor at 8.27 — while nearly 100% of surveyed leaders said they were very likely to renew their AI engagements with Waystar, underscoring the platform's ability to deliver sustained value.
- Top AI execution: Waystar achieved the highest aggregate score for AI execution, including time-to-value, workflow quality, ROI clarity, and security and governance, earning the leading AI operations score of 9.56.
- Superior client-reported outcomes: Waystar exceeded all category benchmarks for client-reported AI operations outcomes, earning the highest KPI score in the study at 9.56, compared to the 7.75 benchmark, reflecting strong performance in denial prevention, workflow automation quality, and payer responsiveness.
"We are grateful for the industry recognition and trust in Waystar's AI-powered platform to deliver meaningful outcomes," said Matt Hawkins, Chief Executive Officer of Waystar. "Our strength comes from four interconnected pillars: mission-critical infrastructure, unmatched proprietary data, an extensively deployed network, and scaled distribution paired with deep domain expertise. As we advance toward a fully autonomous revenue cycle, we are focused on scaling agentic AI that acts continuously within workflows, learns from outcomes, and generates high ROI with minimal intervention."
The independent study highlights the operational impact of Waystar AltitudeAI™, embedded across Waystar's platform to achieve significant results at scale. In less than a year, Waystar AltitudeAI has prevented $15 billion in denials and accelerated appeal package generation by 90% — reducing work that once took days to minutes. The Waystar platform consistently achieves approximately 99% clean claim and first-pass acceptance rates, driving faster and more accurate reimbursement.
Piedmont Healthcare, a Georgia-based health system, leverages AI capabilities across Waystar's platform. "We've been automating and leveraging more and more AI to get authorizations done without any human touch. When you're talking about trying to speed up processes or when you don't have enough people to get the job done, that makes a big difference," said Sheila Granda, Executive Director of Financial and Operational Effectiveness at Piedmont Healthcare. "Leveraging Waystar, our accuracy rate is in the 90s, which is tremendous."
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts. The words "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "seek," "foreseeable," the negative version of these words, or similar terms and phrases are intended to identify forward-looking statements. The forward-looking statements contained in this press release are based on management's current expectations and are inherently subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. These risks and uncertainties include, but are not limited to, risks and uncertainties associated with the consummation of the offering and other risks described in Waystar's Annual Report on Form 10-K for the year ended December 31, 2024 and any subsequent filings with the SEC. Except as required by law, Waystar has no obligation to update any of these forward-looking statements to conform these statements to actual results or revised expectations.
About Waystar
Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves over 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals list. Waystar's enterprise-grade platform annually processes over 7.5 billion healthcare payment transactions, including over $2.4 trillion in annual gross claims and spanning approximately 60% of U.S. patients and one in three U.S. hospital discharges. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.
Media Contact
Kristin Lee
kristin.lee@waystar.com
Investor Contact
investors@waystar.com
SOURCE Waystar
FAQ**
How does Waystar Holding Corp. WAY plan to maintain its top ranking in client satisfaction as AI integration continues to evolve in the revenue cycle management industry?
What strategies does Waystar Holding Corp. WAY employ to achieve its impressive 99% clean claim and first-pass acceptance rates reported in the survey?
Can you provide more details on how Waystar Holding Corp. WAY's proprietary data contributes to its AI capabilities and overall client outcomes in revenue cycle management?
With the significant results achieved through Waystar AltitudeAI™, what are the company's future plans for expanding AI functionalities in their healthcare payment platform?
**MWN-AI FAQ is based on asking OpenAI questions about Waystar Holding Corp. (NASDAQ: WAY).
NASDAQ: WAY
WAY Trading
-1.16% G/L:
$25.52 Last:
599,191 Volume:
$25.74 Open:
